Sophia Randolph
2023
In 2023, Sophia Randolph earned a total compensation of $1.4M as Chief Medical Officer at ALX ONCOLOGY HOLDINGS, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,000 |
|---|---|
| Option Awards | $461,652 |
| Salary | $510,000 |
| Stock Awards | $199,240 |
| Total | $1,374,892 |
Randolph received $510K in salary, accounting for 37% of the total pay in 2023.
Randolph also received $204K in non-equity incentive plan, $461.7K in option awards and $199.2K in stock awards.
Rankings
In 2023, Sophia Randolph's compensation ranked 795th out of 2,311 executives tracked by ExecPay. In other words, Randolph earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 795 out of 2,311 | 66th |
Division Manufacturing | 461 out of 1,247 | 63rd |
Major group Chemicals And Allied Products | 315 out of 705 | 55th |
Industry group Drugs | 307 out of 676 | 55th |
Industry Pharmaceutical Preparations | 211 out of 490 | 57th |
Source: SEC filing on April 22, 2024.
Randolph's colleagues
We found three more compensation records of executives who worked with Sophia Randolph at ALX ONCOLOGY HOLDINGS in 2023.